NEO214

1 Cited Publications
Revisión del cliente

Based on 1 publication(s) in Google Scholar

NEO214 is an autophagy inhibitor and a covalent conjugate of the PDE4 inhibitor Rolipram (HY-16900) and perillyl alcohol (HY-N7000). It has anti-cancer activity and blood-brain barrier (BBB) permeability. Over sex. NEO214 prevents autophagy-lysosome fusion, thereby blocking autophagic flux and triggering glioma cell death. The process involves mTOR activation, andTFEB(Transcription Factor EB) aggregation. NEO214 inhibitionMacroautophagy/autophagy in glioblastoma cells has the potential to overcome chemotherapy resistance in glioblastoma.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 98.0%
  • No. CAS: 1361198-80-2
  • Fòrmula: C27H35NO5
  • Peso molecular:453.57
  • Almacenamiento:
    Pure form   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) NEO214

More

Ver todos los productos específicos de isoformas mTOR

More
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00